Cantel Medical (CMN) Reports In-Line Q4 EPS

Cantel Medical (NYSE: CMN) reported Q4 EPS of $0.26, in-line with the analyst estimate of $0.26. Revenue for the quarter came in at $131.38 million versus the consensus estimate of $125.14 million.

For earnings history and earnings-related data on Cantel Medical (CMN) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Ross Stores raises 2026 outlook after strong second-quarter results
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth